Interventional neuroscience service provider Cutting Edge Health has formed a partnership with the mental wellness app Limitless Guided Visualizations, aiming to augment patient outcomes during and between ketamine and neuromodulation therapies.
The collaboration introduces a blend of neurological treatments and guided mindset support, providing patients with tools to address complex health conditions such as pain and mood disturbance and bolster cognitive patterns.
Go deeper with GlobalData
Limitless founder Cali Wilson said: “[Cutting Edge Health CEO] Dr Landrum’s dedication to incorporating metacognitive healing alongside medical interventions is a model for the future of integrative health.
“His forward-thinking approach shows patients they’re not only receiving expert medical care but also gaining tools to nurture their inner resilience and long-term well-being.”
Claimed to be one of the few clinics in the US Midwest to offer an integrated approach, Cutting Edge Health combines various therapies, including transcranial magnetic stimulation (TMS), intravenous (IV) ketamine therapy, and dual sympathetic reset (DSR).
Additionally, it provides at-home transcranial direct current stimulation (tDCS) as part of a remote maintenance programme.
To improve the therapies, Limitless Guided Visualizations are seamlessly integrated into both in-clinic and remote care settings.
Patients can achieve optimal brain states, enhancing the effectiveness of treatments and contributing to sustained results, stated the companies.
Landrum said: “We’re learning how brain connections influence conditions like depression, anxiety, and PTSD and how activating these circuits can break negative cycles. Limitless Guided Visualizations empowers patients to strengthen these connections, reinforcing the positive effects of our interventions for better outcomes.”
According to recent studies, combining medical interventions with metacognitive strategies can lead to reduced anxiety, increased patient engagement, and improved overall outcomes.
Limitless’ app-based Journey Macrodoses and Mindset Microdoses aim to solidify the neural pathways formed by therapies such as ketamine, ensuring the longevity of each therapeutic breakthrough.
The key benefits for patients are claimed to include meaningful engagement through guided audio sessions that encourage active participation in their treatment.
The tailored soundscapes and mindfulness techniques offer calmer and more confident experiences, while the consistent use of these tools can strengthen neural pathways.
This support extends beyond the clinic, with daily mindset exercises and immersive guidance to help patients maintain their progress.
